BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30940396)

  • 1. A survey of core replacements in indole-based HIV-1 attachment inhibitors.
    Wang T; Wallace OB; Zhang Z; Fang H; Yang Z; Robinson BA; Spicer TP; Gong YF; Blair WS; Shi PY; Lin PF; Deshpande M; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1423-1429. PubMed ID: 30940396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives.
    Wang T; Kadow JF; Zhang Z; Yin Z; Gao Q; Wu D; Parker DD; Yang Z; Zadjura L; Robinson BA; Gong YF; Spicer TP; Blair WS; Shi PY; Yamanaka G; Lin PF; Meanwell NA
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5140-5. PubMed ID: 19664921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity.
    Meanwell NA; Wallace OB; Wang H; Deshpande M; Pearce BC; Trehan A; Yeung KS; Qiu Z; Wright JJ; Robinson BA; Gong YF; Wang HG; Spicer TP; Blair WS; Shi PY; Lin PF
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5136-9. PubMed ID: 19632112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of HIV-1 attachment. Part 10. The discovery and structure-activity relationships of 4-azaindole cores.
    Wang T; Yang Z; Zhang Z; Gong YF; Riccardi KA; Lin PF; Parker DD; Rahematpura S; Mathew M; Zheng M; Meanwell NA; Kadow JF; Bender JA
    Bioorg Med Chem Lett; 2013 Jan; 23(1):213-7. PubMed ID: 23200254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of HIV-1 attachment: The discovery and structure-activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophore.
    Swidorski JJ; Liu Z; Yin Z; Wang T; Carini DJ; Rahematpura S; Zheng M; Johnson K; Zhang S; Lin PF; Parker DD; Li W; Meanwell NA; Hamann LG; Regueiro-Ren A
    Bioorg Med Chem Lett; 2016 Jan; 26(1):160-7. PubMed ID: 26584882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjects.
    Wang T; Yin Z; Zhang Z; Bender JA; Yang Z; Johnson G; Yang Z; Zadjura LM; D'Arienzo CJ; DiGiugno Parker D; Gesenberg C; Yamanaka GA; Gong YF; Ho HT; Fang H; Zhou N; McAuliffe BV; Eggers BJ; Fan L; Nowicka-Sans B; Dicker IB; Gao Q; Colonno RJ; Lin PF; Meanwell NA; Kadow JF
    J Med Chem; 2009 Dec; 52(23):7778-87. PubMed ID: 19769332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of HIV-1 attachment. Part 7: indole-7-carboxamides as potent and orally bioavailable antiviral agents.
    Yeung KS; Qiu Z; Xue Q; Fang H; Yang Z; Zadjura L; D'Arienzo CJ; Eggers BJ; Riccardi K; Shi PY; Gong YF; Browning MR; Gao Q; Hansel S; Santone K; Lin PF; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2013 Jan; 23(1):198-202. PubMed ID: 23200252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 12. Structure-activity relationships associated with 4-fluoro-6-azaindole derivatives leading to the identification of 1-(4-benzoylpiperazin-1-yl)-2-(4-fluoro-7-[1,2,3]triazol-1-yl-1h-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-585248).
    Regueiro-Ren A; Xue QM; Swidorski JJ; Gong YF; Mathew M; Parker DD; Yang Z; Eggers B; D'Arienzo C; Sun Y; Malinowski J; Gao Q; Wu D; Langley DR; Colonno RJ; Chien C; Grasela DM; Zheng M; Lin PF; Meanwell NA; Kadow JF
    J Med Chem; 2013 Feb; 56(4):1656-69. PubMed ID: 23360431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of HIV-1 attachment. Part 11: the discovery and structure-activity relationships associated with 4,6-diazaindole cores.
    Bender JA; Yang Z; Eggers B; Gong YF; Lin PF; Parker DD; Rahematpura S; Zheng M; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2013 Jan; 23(1):218-22. PubMed ID: 23206859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of the 6-azaindole containing HIV-1 attachment inhibitor pro-drug, BMS-663068.
    Chen K; Risatti C; Bultman M; Soumeillant M; Simpson J; Zheng B; Fanfair D; Mahoney M; Mudryk B; Fox RJ; Hsaio Y; Murugesan S; Conlon DA; Buono FG; Eastgate MD
    J Org Chem; 2014 Sep; 79(18):8757-67. PubMed ID: 25144249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns.
    Meanwell NA; Wallace OB; Fang H; Wang H; Deshpande M; Wang T; Yin Z; Zhang Z; Pearce BC; James J; Yeung KS; Qiu Z; Kim Wright JJ; Yang Z; Zadjura L; Tweedie DL; Yeola S; Zhao F; Ranadive S; Robinson BA; Gong YF; Wang HG; Spicer TP; Blair WS; Shi PY; Colonno RJ; Lin PF
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1977-81. PubMed ID: 19251416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterobiaryl human immunodeficiency virus entry inhibitors.
    Lu RJ; Tucker JA; Pickens J; Ma YA; Zinevitch T; Kirichenko O; Konoplev V; Kuznetsova S; Sviridov S; Brahmachary E; Khasanov A; Mikel C; Yang Y; Liu C; Wang J; Freel S; Fisher S; Sullivan A; Zhou J; Stanfield-Oakley S; Baker B; Sailstad J; Greenberg M; Bolognesi D; Bray B; Koszalka B; Jeffs P; Jeffries C; Chucholowski A; Sexton C
    J Med Chem; 2009 Jul; 52(14):4481-7. PubMed ID: 19534463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing.
    Zhao T; Meng Q; Kang D; Ji J; De Clercq E; Pannecouque C; Liu X; Zhan P
    Eur J Med Chem; 2019 Nov; 182():111619. PubMed ID: 31434039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double Arylation of the Indole Side Chain of Tri- and Tetrapodal Tryptophan Derivatives Renders Highly Potent HIV-1 and EV-A71 Entry Inhibitors†.
    Martí-Marí O; Martínez-Gualda B; de la Puente-Secades S; Mills A; Quesada E; Abdelnabi R; Sun L; Boonen A; Noppen S; Neyts J; Schols D; Camarasa MJ; Gago F; San-Félix A
    J Med Chem; 2021 Jul; 64(14):10027-10046. PubMed ID: 34229438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of HIV-1 attachment. Part 8: the effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors.
    Yeung KS; Qiu Z; Yin Z; Trehan A; Fang H; Pearce B; Yang Z; Zadjura L; D'Arienzo CJ; Riccardi K; Shi PY; Spicer TP; Gong YF; Browning MR; Hansel S; Santone K; Barker J; Coulter T; Lin PF; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2013 Jan; 23(1):203-8. PubMed ID: 23200249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir.
    Wang T; Ueda Y; Zhang Z; Yin Z; Matiskella J; Pearce BC; Yang Z; Zheng M; Parker DD; Yamanaka GA; Gong YF; Ho HT; Colonno RJ; Langley DR; Lin PF; Meanwell NA; Kadow JF
    J Med Chem; 2018 Jul; 61(14):6308-6327. PubMed ID: 29920093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of indole derivatives as Vif inhibitors.
    Pu C; Luo RH; Zhang M; Hou X; Yan G; Luo J; Zheng YT; Li R
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4150-4155. PubMed ID: 28754362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of substituted guanidine indole derivatives as potential inhibitors of HIV-1 Tat-TAR interaction.
    Wang J; Wang Y; Li Z; Zhan P; Bai R; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Med Chem; 2014; 10(7):738-46. PubMed ID: 24605773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide.
    La Regina G; Coluccia A; Brancale A; Piscitelli F; Gatti V; Maga G; Samuele A; Pannecouque C; Schols D; Balzarini J; Novellino E; Silvestri R
    J Med Chem; 2011 Mar; 54(6):1587-98. PubMed ID: 21366296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico study on indole derivatives as anti HIV-1 agents: a combined docking, molecular dynamics and 3D-QSAR study.
    Balupuri A; Gadhe CG; Balasubramanian PK; Kothandan G; Cho SJ
    Arch Pharm Res; 2014 Aug; 37(8):1001-15. PubMed ID: 24338530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.